Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07350759 · ClinicalTrials.gov registry record
Observational Study Designed to Detect Decompensation of Congestive Heart Failure (dCHF) Using a Non-Invasive Wearable Device
A clinical trial of Decompensated Chronic Heart Failure, sponsored by CHFDX.
- Recruiting
- Registry status
- 60
- Enrollment target
- 2
- Study locations
NCT07350759: Recruiting study of Decompensated Chronic Heart Failure, sponsored by CHFDX.
NCT07350759 is a study of Decompensated Chronic Heart Failure that is actively recruiting participants, run by CHFDX. The registered enrollment target is 60 participants. The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07350759, a study of Decompensated Chronic Heart Failure, is actively recruiting participants, sponsored by CHFDX.
- RECRUITING
- Registry status
- 60 participants
- Enrollment target
- 2
- Study locations
Study Summary
This is a prospective, observational pilot study designed to develop a mathematical algorithm capable of predicting decompensation of congestive heart failure (dCHF) using physiologic data collected from a non-invasive wearable device. Participants with a remote hemodynamic pulmonary artery pressure monitor will wear a wearable device continuously for up to 12 months. Wearable data will be analyzed in relation to the hemodynamic monitor defined sentinel events of heart failure decompensation to identify predictive signal patterns. Optional biospecimen (DNA, blood, urine) and voice sample collection will support future biomarker discovery.
Primary Outcome
Identification of reproducible changes in wearable physiologic data that occur in the 1-7 days preceding a hemodynamic monitoring device detection of elevated pulmonary artery pressure sustained over 2 days defined as a sentinel event of decompensated CHF.
Conditions Studied
Interventions
- DEVICE wearable ring device with multiple embedded sensors to detect heart rate, SVO2, respiratory rate, heart rate variability and a number of other related physiologic parameters
Study Locations (2)
Florida
- USF Office of Clinical Research - Tampa
- USF - Tampa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2026-03-09 |
| Est. Completion | 2026-12-31 |
What NCT07350759 shows while recruiting
NCT07350759 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 60 participants, a relatively small participant target.
The record links to 1 condition, with Decompensated Chronic Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which wearable ring device with multiple embedded sensors to detect heart rate, SVO2, respiratory rate, heart rate variability and a number of other related physiologic parameters is the first listed.
NCT07350759 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT07350759 about?
NCT07350759 is a clinical study titled "Observational Study Designed to Detect Decompensation of Congestive Heart Failure (dCHF) Using a Non-Invasive Wearable Device". This is a prospective, observational pilot study designed to develop a mathematical algorithm capable of predicting decompensation of congestive heart failure (dCHF) using physiologic data collected from a non-invasive wearable device. Participants with a remote hemodynamic pulmonary artery pressure...
What is the current status of trial NCT07350759?
This trial is currently recruiting. The enrollment target is 60 participants. The study started on 2026-03-09. Estimated completion is 2026-12-31.
What conditions does trial NCT07350759 study?
This clinical trial studies the following conditions: Decompensated Chronic Heart Failure.
What interventions are being tested in trial NCT07350759?
The interventions under investigation include: wearable ring device with multiple embedded sensors to detect heart rate, SVO2, respiratory rate, heart rate variability and a number of other related physiologic parameters (DEVICE).
Who is sponsoring clinical trial NCT07350759?
This trial is sponsored by CHFDX, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07350759 being conducted?
This trial has 2 study locations across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI